Table 5

Evaluation of exposure to antimicrobials in both subsets of patients according to the therapeutic strategy employed

Exposure to antimicrobialsPatients empirically treated (n=152)Patients treated according to antigen results (n=25)
Broad-spectrum antimicrobials
 Ceftriaxone, IV35.935.2
 Levofloxacin, IV16.115.8
 Levofloxacin, oral26.10
 Amoxicillin–clavulanate, IV3.34.4
 Amoxicillin–clavulanate, oral69.610.0
 Cefditoren, oral36.74.0
Narrow-spectrum antimicrobials
 Azithromycin, IV32.835.0
 Azithromycin, oral15.811.1
 Amoxicillin, oral0176.4
  • Data are presented as defined daily doses per 100 patient days.

  • IV, intravenous.